BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:OJR520 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of OJR520\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07235059-938@assetmemo.bio
DTSTAMP:20261121T005436Z
DTSTART;VALUE=DATE:20280121
DTEND;VALUE=DATE:20280122
SUMMARY:OJR520: Phase 1 readout est. (NCT07235059)
DESCRIPTION:OJR520\, phase 1\, Chronic Kidney Disease.\nStudy: Safety\, Tol
 erability\, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Vol
 unteers and Participants With Chronic Kidney Disease\nEstimated primary co
 mpletion: 21 January 2028. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/ojr520#upcoming-events\nRegistry record: https://clinicaltrials.gov/
 study/NCT07235059
URL:https://assetmemo.bio/drug/ojr520#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
